TRDA R&D to Revenue
Entrada Therapeutics Inc · R&D to Revenue
TRDA R&D to Revenue
Latest reported3938.64%period ending
TRDA Quarterly R&D/Revenue (0.00% → 3938.64%)
Latest values, visible window
High-resolution chart · PNG
TRDA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 3,938.6414% | |
| 3,777.6% | |
| 2,614.0878% | |
| 2,376.7658% | |
| 1,942.4103% | |
| 156.0171% | |
| 89.3256% | |
| 159.719% | |
| 33.83% | |
| 48.3897% | |
| 67.6042% | |
| 50.7397% | |
| 144.7441% | |
| 91.4568% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |